Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials93
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review78
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a65
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis64
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin62
Neonatal ocular prophylaxis in the United States: is it still necessary?56
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex51
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis50
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies41
Challenges in preserving antibiotic effectiveness: time for a novel approach39
Visceral leishmaniasis elimination in India: progress and the road ahead37
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future37
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies35
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia34
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines34
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72032
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis28
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis27
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies26
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges26
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators24
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?22
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections22
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’22
0.090250015258789